{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:47:29Z","timestamp":1790160449910,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T00:00:00Z","timestamp":1381536000000},"content-version":"vor","delay-in-days":315,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"},{"name":"Funda\u00e7\u00e3o de Apoio a Pesquisa Cientifica e Tecnol\u00f3gica do Estado de Santa Catarina"},{"name":"Financiadora de Estudos e Projetos (FINEP)\/CNPq"},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.pbb.2012.09.011","type":"journal-article","created":{"date-parts":[[2012,9,23]],"date-time":"2012-09-23T10:03:21Z","timestamp":1348394601000},"page":"408-417","source":"Crossref","is-referenced-by-count":35,"title":["The role of the NMDA receptors and l-arginine\u2013nitric oxide\u2013cyclic guanosine monophosphate pathway in the antidepressant-like effect of duloxetine in the forced swimming test"],"prefix":"10.1016","volume":"103","author":[{"given":"Andr\u00e9a D.E.","family":"Zomkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio P.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson H.","family":"Gabilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2012.09.011_bb0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2005.11.023","article-title":"Evidence for the involvement of l-arginine\u2013nitric oxide cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice","volume":"168","author":"Almeida","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.09.011_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.103.063362","article-title":"Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model","volume":"310","author":"Angulo","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2012.09.011_bb0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pbb.2012.09.011_bb0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/AAP.0b013e3181df2645","article-title":"Duloxetine: a review of its pharmacology and use in chronic pain management","volume":"35","author":"Bellingham","year":"2010","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.pbb.2012.09.011_bb0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.09.011_bb0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.pnpbp.2009.02.003","article-title":"Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission","volume":"33","author":"Binfar\u00e9","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.09.011_bb0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","article-title":"Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain","volume":"48","author":"Bomholt","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2012.09.011_bb0040","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/sj.npp.1301039","article-title":"Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice","volume":"31","author":"Boyce-Rustay","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2012.09.011_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02761776","article-title":"Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study","volume":"10","author":"Boyer","year":"1998","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pbb.2012.09.011_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpsychires.2004.05.005","article-title":"Onset of action for duloxetine 60mg once daily: double-blind, placebo-controlled studies","volume":"39","author":"Brannan","year":"2005","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pbb.2012.09.011_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2008.08.033","article-title":"Antidepressant-like effect of folic acid: involvement of NMDA receptors and l\u2013arginine\u2013nitric oxide\u2013cyclic guanosine monophosphate pathway","volume":"598","author":"Brocardo","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/00023210-200923060-00006","article-title":"Duloxetine: a review of its use in the treatment of generalized anxiety disorder","volume":"23","author":"Carter","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2012.09.011_bb0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1590\/S0102-86502007000500005","article-title":"Antidepressant behavioral effects of duloxetine and fluoxetine in the rat forced swimming test","volume":"22","author":"Ciulla","year":"2007","journal-title":"Acta Cir Bras"},{"key":"10.1016\/j.pbb.2012.09.011_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0b013e3280117733","article-title":"Animal models of mood disorders: recent developments","volume":"20","author":"Cryan","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pbb.2012.09.011_bb0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2012.09.011_bb0080","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1097\/00001756-200011270-00022","article-title":"Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice","volume":"11","author":"Da Silva","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2012.09.011_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euroneuro.2004.01.002","article-title":"Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial","volume":"14","author":"Detke","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0090","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.pnpbp.2007.02.008","article-title":"Involvement of l-arginine\u2013nitric oxide\u2013cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice","volume":"31","author":"Dhir","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.09.011_bb0095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/phrs.1997.0245","article-title":"Anxiolytic and antidepressant properties of methylene blue in animal models","volume":"36","author":"Eroglu","year":"1997","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pbb.2012.09.011_bb0100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.euroneuro.2007.07.011","article-title":"Nitric oxide involvement in the antidepressant-like of acute lithium effects administration in the mouse forced swimming test","volume":"18","author":"Ghasemi","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-009-1609-1","article-title":"NMDA\/receptor nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test","volume":"206","author":"Ghasemi","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2012.09.011_bb0105","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/0269881109104845","article-title":"NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test","volume":"24","author":"Ghasemi","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00191-0","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice. Acute treatments are active in the forced swim test","volume":"372","author":"Harkin","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0130","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0028-3908(03)00030-3","article-title":"Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors","volume":"44","author":"Harkin","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2012.09.011_bb0125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0024-3205(02)01561-8","article-title":"NMDA receptor involvement in imipramine withdrawal associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus","volume":"71","author":"Harvey","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2012.09.011_bb0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-4328(02)00084-0","article-title":"Reduction of cGMP and nitric oxide has antidepressant like effects in the forced swimming test in rats","volume":"134","author":"Heiberg","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.09.011_bb0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0076-6879(94)33028-X","article-title":"Nitric-oxide synthase assays","volume":"233","author":"Hevel","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0150","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.clinthera.2005.08.010","article-title":"Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder","volume":"27","author":"Hunziker","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.pbb.2012.09.011_bb0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0026-895X(25)11243-1","article-title":"Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels","volume":"35","author":"Javitt","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0160","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-006-0326-2","article-title":"Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects","volume":"185","author":"Joca","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2012.09.011_bb0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2005.06.031","article-title":"Effect of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine\u2013nitric oxide-soluble guanylate cyclase pathway","volume":"165","author":"Kaster","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.09.011_bb0170","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S1461145705005316","article-title":"Involvement of nitric oxide\u2013cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test","volume":"8","author":"Kaster","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0361-9230(00)00282-3","article-title":"Role of nitric oxide in the regulation of monoaminergic neurotransmission","volume":"52","author":"Kiss","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pbb.2012.09.011_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00306-9","article-title":"Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the l-arginine\u2013nitric oxide pathway","volume":"343","author":"Mantovani","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2012.09.011_bb0185","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2011.07.024","article-title":"Involvement of nitric oxide\u2013cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test","volume":"225","author":"Moretti","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.09.011_bb0190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjp.0706188","article-title":"Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats","volume":"145","author":"Owen","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0205","first-page":"595","article-title":"Activation of the NMDA\/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test","volume":"59","author":"Poleszak","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pbb.2012.09.011_bb0200","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00702-011-0630-9","article-title":"A complex interaction between glycine\/NMDA receptors and serotonergic\/noradrenergic antidepressants in the forced swim test in mice","volume":"118","author":"Poleszak","year":"2011","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2012.09.011_bb0210","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pbb.2012.09.011_bb0215","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050555","article-title":"Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test","volume":"136","author":"R\u00e9n\u00e9ric","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2012.09.011_bb0220","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effects of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3z","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2012.09.011_bb0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0166-4328(03)00069-X","article-title":"Involvement of NMDA receptors and l-arginine\u2013nitric oxide pathway in the antidepressant-like effects of zinc in mice","volume":"144","author":"Rosa","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.09.011_bb0230","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pbb.2012.09.011_bb0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004850-200507000-00007","article-title":"Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo","volume":"20","author":"Shelton","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(00)01378-1","article-title":"Nitric oxide modulates N-methyl-D\u2010aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat","volume":"291","author":"Smith","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2012.09.011_bb0240","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1192\/bjp.180.5.396","article-title":"Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis","volume":"180","author":"Smith","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2012.09.011_bb0255","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1126\/science.1353273","article-title":"Nitric oxide: first in a new class of neurotransmitters","volume":"257","author":"Snyder","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pbb.2012.09.011_bb0260","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pbb.2012.09.011_bb0265","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2012.09.011_bb0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-0327(00)00164-6","article-title":"Elevated plasma nitrate levels in depressive states","volume":"63","author":"Suzuki","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pbb.2012.09.011_bb0275","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.biopsych.2007.04.014","article-title":"Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system","volume":"62","author":"Szasz","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.09.011_bb0280","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors","volume":"178","author":"Thase","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2012.09.011_bb0285","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/jcp.0b013e31815a4412","article-title":"Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder","volume":"27","author":"Thase","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(02)00312-1","article-title":"Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice","volume":"140","author":"Volke","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.09.011_bb0300","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjp.0703349","article-title":"Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo","volume":"130","author":"Wegener","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2012.09.011_bb0305","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2012.09.011_bb0310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002139900316","article-title":"Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats","volume":"149","author":"Yildiz","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2012.09.011_bb0315","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2012.09.011_bb0320","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.euroneuro.2010.07.011","article-title":"Involvement of NMDA receptors and l-arginine\u2013nitric oxide\u2013cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test","volume":"20","author":"Zomkowski","year":"2010","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305712002699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305712002699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:01:55Z","timestamp":1744171315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305712002699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0091305712002699"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2012.09.011","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}